Požymis
Behavioral abnormality
Klinikinis pavadinimas: Atypical behavior
Atypical behavior is an abnormality in a person's actions that can be controlled or modulated by the will of the individual. While abnormal behaviors can be difficult to control, they are distinct from other abnormal actions that cannot be affected by the individual's will.
Santrauka
- Taip pat vadinama
- Behavioral changes, Behavioral disorders, Behavioral disturbances, Behavioral problems, Behavioral/psychiatric abnormalities, Behavioural/Psychiatric abnormality, Psychiatric disorders, Psychiatric disturbances, Behavioral symptoms, Behavioural abnormality, Behavioural changes, Behavioural disorders, Behavioural disturbances, Behavioural problems, Behavioural symptoms
- Kūno sistema
- Abnormality of the nervous system
Atskaitos genomasGRCh38hg38
Pozicijos genų ir variantų puslapiuose rodomos pagal šį pasirinkimą šioje naršyklėje.
Read the genes linked to Behavioral abnormality, and the rest of your genome, with one test.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test485 genų susiję su Behavioral abnormality
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Behavioral abnormality. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| GRIN2Bglutamate ionotropic receptor NMDA type subunit 2B | Visada | 1 ligoje |
| LRRC7leucine rich repeat containing 7 | Visada | 1 ligoje |
| ADA2adenosine deaminase 2 | Labai dažnai (80–99%) | 1 ligoje |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Labai dažnai (80–99%) | 1 ligoje |
| APPamyloid beta precursor protein | Labai dažnai (80–99%) | 4 ligose |
| ARG1arginase 1 | Labai dažnai (80–99%) | 1 ligoje |
| ATRXATRX chromatin remodeler | Labai dažnai (80–99%) | 2 ligose |
| CASRcalcium sensing receptor | Labai dažnai (80–99%) | 1 ligoje |
| CHMP2Bcharged multivesicular body protein 2B | Labai dažnai (80–99%) | 3 ligose |
| CPT1Acarnitine palmitoyltransferase 1A | Labai dažnai (80–99%) | 1 ligoje |
| DCXdoublecortin | Labai dažnai (80–99%) | 1 ligoje |
| DYRK1Adual specificity tyrosine phosphorylation regulated kinase 1A | Labai dažnai (80–99%) | 1 ligoje |
| GNA11G protein subunit alpha 11 | Labai dažnai (80–99%) | 1 ligoje |
| GRNgranulin precursor | Labai dažnai (80–99%) | 2 ligose |
| HPRT1hypoxanthine phosphoribosyltransferase 1 | Labai dažnai (80–99%) | 1 ligoje |
| HSD17B10hydroxysteroid 17-beta dehydrogenase 10 | Labai dažnai (80–99%) | 1 ligoje |
| IFNGinterferon gamma | Labai dažnai (80–99%) | 1 ligoje |
| IGF1insulin like growth factor 1 | Labai dažnai (80–99%) | 1 ligoje |
| MAOAmonoamine oxidase A | Labai dažnai (80–99%) | 1 ligoje |
| MAPTmicrotubule associated protein tau | Labai dažnai (80–99%) | 2 ligose |
| MCOLN1mucolipin TRP cation channel 1 | Labai dažnai (80–99%) | 1 ligoje |
| MED12mediator complex subunit 12 | Labai dažnai (80–99%) | 1 ligoje |
| MMADHCmetabolism of cobalamin associated D | Labai dažnai (80–99%) | 1 ligoje |
| MTHFRmethylenetetrahydrofolate reductase | Labai dažnai (80–99%) | 2 ligose |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Labai dažnai (80–99%) | 1 ligoje |
| PRNPprion protein (Kanno blood group) | Labai dažnai (80–99%) | 2 ligose |
| PSEN1presenilin 1 | Labai dažnai (80–99%) | 2 ligose |
| SH2B1SH2B adaptor protein 1 | Labai dažnai (80–99%) | 1 ligoje |
| SHANK3SH3 and multiple ankyrin repeat domains 3 | Labai dažnai (80–99%) | 1 ligoje |
| SQSTM1sequestosome 1 | Labai dažnai (80–99%) | 3 ligose |
| SUCLA2succinate-CoA ligase ADP-forming subunit beta | Labai dažnai (80–99%) | 1 ligoje |
| TBR1T-box brain transcription factor 1 | Labai dažnai (80–99%) | 1 ligoje |
| TMEM106Btransmembrane protein 106B | Labai dažnai (80–99%) | 2 ligose |
| TREM2triggering receptor expressed on myeloid cells 2 | Labai dažnai (80–99%) | 4 ligose |
| TSC1TSC complex subunit 1 | Labai dažnai (80–99%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Labai dažnai (80–99%) | 1 ligoje |
| TYROBPtransmembrane immune signaling adaptor TYROBP | Labai dažnai (80–99%) | 1 ligoje |
| UBTFupstream binding transcription factor | Labai dažnai (80–99%) | 1 ligoje |
| UPF3BUPF3B regulator of nonsense mediated mRNA decay | Labai dažnai (80–99%) | 1 ligoje |
| VCPvalosin containing protein | Labai dažnai (80–99%) | 5 ligose |
Rodyti dar 445 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| WACWW domain containing adaptor with coiled-coil | Labai dažnai (80–99%) | 3 ligose |
| ZDHHC9zDHHC palmitoyltransferase 9 | Labai dažnai (80–99%) | 2 ligose |
| AASSaminoadipate-semialdehyde synthase | Dažnai (30–79%) | 1 ligoje |
| ABCD1ATP binding cassette subfamily D member 1 | Dažnai (30–79%) | 3 ligose |
| AHCYadenosylhomocysteinase | Dažnai (30–79%) | 1 ligoje |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Dažnai (30–79%) | 2 ligose |
| ANGangiogenin | Dažnai (30–79%) | 1 ligoje |
| ANXA11annexin A11 | Dažnai (30–79%) | 1 ligoje |
| APC2APC regulator of Wnt signaling pathway 2 | Dažnai (30–79%) | 1 ligoje |
| AQP4aquaporin 4 | Dažnai (30–79%) | 1 ligoje |
| ARID1AAT-rich interaction domain 1A | Dažnai (30–79%) | 1 ligoje |
| ARID1BAT-rich interaction domain 1B | Dažnai (30–79%) | 1 ligoje |
| ARID2AT-rich interaction domain 2 | Dažnai (30–79%) | 2 ligose |
| ARL6ARF like GTPase 6 | Dažnai (30–79%) | 1 ligoje |
| ASAH1N-acylsphingosine amidohydrolase 1 | Dažnai (30–79%) | 2 ligose |
| ATMATM serine/threonine kinase | Dažnai (30–79%) | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Dažnai (30–79%) | 2 ligose |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Dažnai (30–79%) | 2 ligose |
| ATP7AATPase copper transporting alpha | Dažnai (30–79%) | 1 ligoje |
| ATXN2ataxin 2 | Dažnai (30–79%) | 1 ligoje |
| BBIP1BBSome interacting protein 1 | Dažnai (30–79%) | 1 ligoje |
| BBS1Bardet-Biedl syndrome 1 | Dažnai (30–79%) | 1 ligoje |
| BBS10Bardet-Biedl syndrome 10 | Dažnai (30–79%) | 1 ligoje |
| BBS12Bardet-Biedl syndrome 12 | Dažnai (30–79%) | 1 ligoje |
| BBS2Bardet-Biedl syndrome 2 | Dažnai (30–79%) | 1 ligoje |
| BBS4Bardet-Biedl syndrome 4 | Dažnai (30–79%) | 1 ligoje |
| BBS5Bardet-Biedl syndrome 5 | Dažnai (30–79%) | 1 ligoje |
| BBS7Bardet-Biedl syndrome 7 | Dažnai (30–79%) | 1 ligoje |
| BBS9Bardet-Biedl syndrome 9 | Dažnai (30–79%) | 1 ligoje |
| BICRABRD4 interacting chromatin remodeling complex associated protein | Dažnai (30–79%) | 1 ligoje |
| BMPR1Abone morphogenetic protein receptor type 1A | Dažnai (30–79%) | 1 ligoje |
| BPTFbromodomain PHD finger transcription factor | Dažnai (30–79%) | 1 ligoje |
| BRAFB-Raf proto-oncogene, serine/threonine kinase | Dažnai (30–79%) | 3 ligose |
| BRCA2BRCA2 DNA repair associated | Dažnai (30–79%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Dažnai (30–79%) | 4 ligose |
| CASZ1castor zinc finger 1 | Dažnai (30–79%) | 1 ligoje |
| CC2D2Acoiled-coil and C2 domain containing 2A | Dažnai (30–79%) | 1 ligoje |
| CCNFcyclin F | Dažnai (30–79%) | 2 ligose |
| CDH23cadherin related 23 | Dažnai (30–79%) | 1 ligoje |
| CDONcell adhesion associated, oncogene regulated | Dažnai (30–79%) | 4 ligose |
| CEP19centrosomal protein 19 | Dažnai (30–79%) | 1 ligoje |
| CEP290centrosomal protein 290 | Dažnai (30–79%) | 2 ligose |
| CFAP410cilia and flagella associated protein 410 | Dažnai (30–79%) | 1 ligoje |
| CFAP418cilia and flagella associated protein 418 | Dažnai (30–79%) | 1 ligoje |
| CHCHD10coiled-coil-helix-coiled-coil-helix domain containing 10 | Dažnai (30–79%) | 2 ligose |
| CHD2chromodomain helicase DNA binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| CHEK2checkpoint kinase 2 | Dažnai (30–79%) | 1 ligoje |
| CHRNA7cholinergic receptor nicotinic alpha 7 subunit | Dažnai (30–79%) | 1 ligoje |
| CLCN4Cl-/H+ antiporter 4 | Dažnai (30–79%) | 2 ligose |
| COL1A1collagen type I alpha 1 chain | Dažnai (30–79%) | 1 ligoje |
| CREBBPCREB binding lysine acetyltransferase | Dažnai (30–79%) | 2 ligose |
| CRIPTOcripto, EGF-CFC family member | Dažnai (30–79%) | 4 ligose |
| CTCFCCCTC-binding factor | Dažnai (30–79%) | 1 ligoje |
| CTNNB1catenin beta 1 | Dažnai (30–79%) | 2 ligose |
| CUX2cut like homeobox 2 | Dažnai (30–79%) | 1 ligoje |
| CYP27A1cytochrome P450 family 27 subfamily A member 1 | Dažnai (30–79%) | 1 ligoje |
| DAOD-amino acid oxidase | Dažnai (30–79%) | 1 ligoje |
| DCTN1dynactin subunit 1 | Dažnai (30–79%) | 1 ligoje |
| DDCdopa decarboxylase | Dažnai (30–79%) | 1 ligoje |
| DISP1dispatched RND transporter family member 1 | Dažnai (30–79%) | 4 ligose |
| DLATdihydrolipoamide S-acetyltransferase | Dažnai (30–79%) | 1 ligoje |
| DLL1delta like canonical Notch ligand 1 | Dažnai (30–79%) | 4 ligose |
| DNAJC21DnaJ heat shock protein family (Hsp40) member C21 | Dažnai (30–79%) | 1 ligoje |
| DNM1dynamin 1 | Dažnai (30–79%) | 2 ligose |
| DNMT3ADNA methyltransferase 3 alpha | Dažnai (30–79%) | 1 ligoje |
| DPF2double PHD fingers 2 | Dažnai (30–79%) | 1 ligoje |
| DPYDdihydropyrimidine dehydrogenase | Dažnai (30–79%) | 1 ligoje |
| EBF3EBF transcription factor 3 | Dažnai (30–79%) | 1 ligoje |
| EFL1elongation factor like GTPase 1 | Dažnai (30–79%) | 1 ligoje |
| EHMT1euchromatic histone lysine methyltransferase 1 | Dažnai (30–79%) | 2 ligose |
| ELNelastin | Dažnai (30–79%) | 1 ligoje |
| ELP1elongator acetyltransferase complex subunit 1 | Dažnai (30–79%) | 1 ligoje |
| EP300EP300 lysine acetyltransferase | Dažnai (30–79%) | 1 ligoje |
| EPB41L1erythrocyte membrane protein band 4.1 like 1 | Dažnai (30–79%) | 1 ligoje |
| EPCAMepithelial cell adhesion molecule | Dažnai (30–79%) | 1 ligoje |
| ERBB4erb-b2 receptor tyrosine kinase 4 | Dažnai (30–79%) | 1 ligoje |
| FGF8fibroblast growth factor 8 | Dažnai (30–79%) | 4 ligose |
| FGFR1fibroblast growth factor receptor 1 | Dažnai (30–79%) | 3 ligose |
| FIG4FIG4 phosphoinositide 5-phosphatase | Dažnai (30–79%) | 2 ligose |
| FOXH1forkhead box H1 | Dažnai (30–79%) | 4 ligose |
| FOXP1forkhead box P1 | Dažnai (30–79%) | 1 ligoje |
| FRA16Efragile site, distamycin A type, rare, fra(16)(p12.1) | Dažnai (30–79%) | 1 ligoje |
| FUSFUS RNA binding protein | Dažnai (30–79%) | 3 ligose |
| GABRB3gamma-aminobutyric acid type A receptor subunit beta3 | Dažnai (30–79%) | 1 ligoje |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Dažnai (30–79%) | 1 ligoje |
| GALCgalactosylceramidase | Dažnai (30–79%) | 1 ligoje |
| GAMTguanidinoacetate N-methyltransferase | Dažnai (30–79%) | 1 ligoje |
| GAS1growth arrest specific 1 | Dažnai (30–79%) | 4 ligose |
| GATA4GATA binding protein 4 | Dažnai (30–79%) | 1 ligoje |
| GBE11,4-alpha-glucan branching enzyme 1 | Dažnai (30–79%) | 1 ligoje |
| GLAgalactosidase alpha | Dažnai (30–79%) | 1 ligoje |
| GLE1GLE1 RNA export mediator | Dažnai (30–79%) | 1 ligoje |
| GLI2GLI family zinc finger 2 | Dažnai (30–79%) | 4 ligose |
| GLT8D1glycosyltransferase 8 domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| GNAQG protein subunit alpha q | Dažnai (30–79%) | 1 ligoje |
| GNB1G protein subunit beta 1 | Dažnai (30–79%) | 1 ligoje |
| GPRC5BG protein-coupled receptor class C group 5 member B | Dažnai (30–79%) | 1 ligoje |
| GRIA3glutamate ionotropic receptor AMPA type subunit 3 | Dažnai (30–79%) | 1 ligoje |
| GRIN1glutamate ionotropic receptor NMDA type subunit 1 | Dažnai (30–79%) | 1 ligoje |
| GRIN2Aglutamate ionotropic receptor NMDA type subunit 2A | Dažnai (30–79%) | 2 ligose |
| HDAC4histone deacetylase 4 | Dažnai (30–79%) | 1 ligoje |
| HEPACAMhepatic and glial cell adhesion molecule | Dažnai (30–79%) | 1 ligoje |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Dažnai (30–79%) | 1 ligoje |
| HNRNPA1heterogeneous nuclear ribonucleoprotein A1 | Dažnai (30–79%) | 1 ligoje |
| HSPG2heparan sulfate proteoglycan 2 | Dažnai (30–79%) | 1 ligoje |
| HTRA1HtrA serine peptidase 1 | Dažnai (30–79%) | 1 ligoje |
| HTThuntingtin | Dažnai (30–79%) | 1 ligoje |
| IFT172intraflagellar transport 172 | Dažnai (30–79%) | 1 ligoje |
| IFT27intraflagellar transport 27 | Dažnai (30–79%) | 1 ligoje |
| IFT74intraflagellar transport 74 | Dažnai (30–79%) | 1 ligoje |
| IQSEC2IQ motif and Sec7 domain ArfGEF 2 | Dažnai (30–79%) | 1 ligoje |
| KCNAB2potassium voltage-gated channel subfamily A regulatory beta subunit 2 | Dažnai (30–79%) | 1 ligoje |
| KCNT1potassium sodium-activated channel subfamily T member 1 | Dažnai (30–79%) | 2 ligose |
| KIF15kinesin family member 15 | Dažnai (30–79%) | 1 ligoje |
| KLF13KLF transcription factor 13 | Dažnai (30–79%) | 1 ligoje |
| KMT2Alysine methyltransferase 2A | Dažnai (30–79%) | 1 ligoje |
| KMT2Clysine methyltransferase 2C | Dažnai (30–79%) | 1 ligoje |
| KRASKRas proto-oncogene, GTPase | Dažnai (30–79%) | 2 ligose |
| KYkyphoscoliosis peptidase | Dažnai (30–79%) | 1 ligoje |
| L2HGDHL-2-hydroxyglutarate dehydrogenase | Dažnai (30–79%) | 1 ligoje |
| LMX1BLIM homeobox transcription factor 1 beta | Dažnai (30–79%) | 1 ligoje |
| LRP12LDL receptor related protein 12 | Dažnai (30–79%) | 1 ligoje |
| LUZP1leucine zipper protein 1 | Dažnai (30–79%) | 1 ligoje |
| LZTFL1leucine zipper transcription factor like 1 | Dažnai (30–79%) | 1 ligoje |
| MAGEL2MAGE family member L2 | Dažnai (30–79%) | 6 ligose |
| MAPK10mitogen-activated protein kinase 10 | Dažnai (30–79%) | 1 ligoje |
| MATR3matrin 3 | Dažnai (30–79%) | 1 ligoje |
| MED13Lmediator complex subunit 13L | Dažnai (30–79%) | 1 ligoje |
| MEN1menin 1 | Dažnai (30–79%) | 1 ligoje |
| MKKSMKKS centrosomal shuttling protein | Dažnai (30–79%) | 1 ligoje |
| MKRN3makorin ring finger protein 3 | Dažnai (30–79%) | 1 ligoje |
| MKS1MKS transition zone complex subunit 1 | Dažnai (30–79%) | 1 ligoje |
| MLC1modulator of VRAC current 1 | Dažnai (30–79%) | 1 ligoje |
| MLH1mutL homolog 1 | Dažnai (30–79%) | 1 ligoje |
| MLXIPLMLX interacting protein like | Dažnai (30–79%) | 1 ligoje |
| MMP23Bmatrix metallopeptidase 23B | Dažnai (30–79%) | 1 ligoje |
| MSH2mutS homolog 2 | Dažnai (30–79%) | 1 ligoje |
| MSH6mutS homolog 6 | Dažnai (30–79%) | 1 ligoje |
| MSL3MSL complex subunit 3 | Dažnai (30–79%) | 1 ligoje |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Dažnai (30–79%) | 1 ligoje |
| MUTYHmutY DNA glycosylase | Dažnai (30–79%) | 1 ligoje |
| NDNnecdin, MAGE family member | Dažnai (30–79%) | 4 ligose |
| NEFHneurofilament heavy chain | Dažnai (30–79%) | 1 ligoje |
| NEK1NIMA related kinase 1 | Dažnai (30–79%) | 1 ligoje |
| NF1neurofibromin 1 | Dažnai (30–79%) | 1 ligoje |
| NIPA1NIPA magnesium transporter 1 | Dažnai (30–79%) | 1 ligoje |
| NIPA2NIPA magnesium transporter 2 | Dažnai (30–79%) | 1 ligoje |
| NODALnodal growth differentiation factor | Dažnai (30–79%) | 4 ligose |
| NOTCH2NLCnotch 2 N-terminal like C | Dažnai (30–79%) | 2 ligose |
| NPAP1nuclear pore associated protein 1 | Dažnai (30–79%) | 1 ligoje |
| NPATnuclear protein, coactivator of histone transcription | Dažnai (30–79%) | 1 ligoje |
| NPHP1nephrocystin 1 | Dažnai (30–79%) | 1 ligoje |
| NR3C1nuclear receptor subfamily 3 group C member 1 | Dažnai (30–79%) | 1 ligoje |
| NSD1nuclear receptor binding SET domain protein 1 | Dažnai (30–79%) | 2 ligose |
| NSDHLNAD(P) dependent 3-beta-hydroxysteroid dehydrogenase NSDHL | Dažnai (30–79%) | 1 ligoje |
| OCA2OCA2 melanosomal transmembrane protein | Dažnai (30–79%) | 3 ligose |
| OPTNoptineurin | Dažnai (30–79%) | 1 ligoje |
| PCDH19protocadherin 19 | Dažnai (30–79%) | 1 ligoje |
| PDPNpodoplanin | Dažnai (30–79%) | 1 ligoje |
| PEX1peroxisomal biogenesis factor 1 | Dažnai (30–79%) | 1 ligoje |
| PEX10peroxisomal biogenesis factor 10 | Dažnai (30–79%) | 1 ligoje |
| PEX11Bperoxisomal biogenesis factor 11 beta | Dažnai (30–79%) | 1 ligoje |
| PEX12peroxisomal biogenesis factor 12 | Dažnai (30–79%) | 1 ligoje |
| PEX13peroxisomal biogenesis factor 13 | Dažnai (30–79%) | 1 ligoje |
| PEX14peroxisomal biogenesis factor 14 | Dažnai (30–79%) | 1 ligoje |
| PEX16peroxisomal biogenesis factor 16 | Dažnai (30–79%) | 1 ligoje |
| PEX19peroxisomal biogenesis factor 19 | Dažnai (30–79%) | 1 ligoje |
| PEX2peroxisomal biogenesis factor 2 | Dažnai (30–79%) | 1 ligoje |
| PEX26peroxisomal biogenesis factor 26 | Dažnai (30–79%) | 1 ligoje |
| PEX3peroxisomal biogenesis factor 3 | Dažnai (30–79%) | 1 ligoje |
| PEX5peroxisomal biogenesis factor 5 | Dažnai (30–79%) | 1 ligoje |
| PEX6peroxisomal biogenesis factor 6 | Dažnai (30–79%) | 1 ligoje |
| PFN1profilin 1 | Dažnai (30–79%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Dažnai (30–79%) | 1 ligoje |
| PLCH1phospholipase C eta 1 | Dažnai (30–79%) | 1 ligoje |
| PMS1PMS1 homolog 1, mismatch repair system component | Dažnai (30–79%) | 1 ligoje |
| PMS2PMS1 homolog 2, mismatch repair system component | Dažnai (30–79%) | 1 ligoje |
| POLD1DNA polymerase delta 1, catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| POLEDNA polymerase epsilon, catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| POLGDNA polymerase gamma, catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| PPOXprotoporphyrinogen oxidase | Dažnai (30–79%) | 1 ligoje |
| PRDM16PR/SET domain 16 | Dažnai (30–79%) | 1 ligoje |
| PRDM8PR/SET domain 8 | Dažnai (30–79%) | 1 ligoje |
| PRKCZprotein kinase C zeta | Dažnai (30–79%) | 1 ligoje |
| PRPHperipherin | Dažnai (30–79%) | 1 ligoje |
| PSMC3proteasome 26S subunit, ATPase 3 | Dažnai (30–79%) | 1 ligoje |
| PSMD12proteasome 26S subunit, non-ATPase 12 | Dažnai (30–79%) | 1 ligoje |
| PTCH1patched 1 | Dažnai (30–79%) | 4 ligose |
| PWAR1Prader Willi/Angelman region RNA 1 | Dažnai (30–79%) | 1 ligoje |
| PWRN1Prader-Willi region non-protein coding RNA 1 | Dažnai (30–79%) | 1 ligoje |
| RAC1Rac family small GTPase 1 | Dažnai (30–79%) | 1 ligoje |
| RAI1retinoic acid induced 1 | Dažnai (30–79%) | 2 ligose |
| REREarginine-glutamic acid dipeptide repeats | Dažnai (30–79%) | 2 ligose |
| RHOBTB2Rho related BTB domain containing 2 | Dažnai (30–79%) | 1 ligoje |
| RPS20ribosomal protein S20 | Dažnai (30–79%) | 1 ligoje |
| SATB1SATB homeobox 1 | Dažnai (30–79%) | 1 ligoje |
| SATB2SATB homeobox 2 | Dažnai (30–79%) | 2 ligose |
| SBDSSBDS ribosome maturation factor | Dažnai (30–79%) | 1 ligoje |
| SCAPERS-phase cyclin A associated protein in the ER | Dažnai (30–79%) | 1 ligoje |
| SCLT1sodium channel and clathrin linker 1 | Dažnai (30–79%) | 1 ligoje |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Dažnai (30–79%) | 2 ligose |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Dažnai (30–79%) | 1 ligoje |
| SDCCAG8SHH signaling and ciliogenesis regulator SDCCAG8 | Dažnai (30–79%) | 1 ligoje |
| SEMA4Asemaphorin 4A | Dažnai (30–79%) | 1 ligoje |
| SHHsonic hedgehog signaling molecule | Dažnai (30–79%) | 4 ligose |
| SIM1SIM bHLH transcription factor 1 | Dažnai (30–79%) | 1 ligoje |
| SIN3ASIN3 transcription regulator family member A | Dažnai (30–79%) | 1 ligoje |
| SIX3SIX homeobox 3 | Dažnai (30–79%) | 4 ligose |
| SKISKI proto-oncogene | Dažnai (30–79%) | 1 ligoje |
| SLC1A3solute carrier family 1 member 3 | Dažnai (30–79%) | 1 ligoje |
| SLC2A1solute carrier family 2 member 1 | Dažnai (30–79%) | 1 ligoje |
| SLC38A3solute carrier family 38 member 3 | Dažnai (30–79%) | 2 ligose |
| SLC46A1solute carrier family 46 member 1 | Dažnai (30–79%) | 1 ligoje |
| SMARCA4SWI/SNF related BAF chromatin remodeling complex subunit ATPase 4 | Dažnai (30–79%) | 1 ligoje |
| SMARCB1SWI/SNF related BAF chromatin remodeling complex subunit B1 | Dažnai (30–79%) | 1 ligoje |
| SMARCC2SWI/SNF related BAF chromatin remodeling complex subunit C2 | Dažnai (30–79%) | 1 ligoje |
| SMARCD1SWI/SNF related BAF chromatin remodeling complex subunit D1 | Dažnai (30–79%) | 1 ligoje |
| SMARCE1SWI/SNF related BAF chromatin remodeling complex subunit E1 | Dažnai (30–79%) | 1 ligoje |
| SMC1Astructural maintenance of chromosomes 1A | Dažnai (30–79%) | 1 ligoje |
| SNORD115-1small nucleolar RNA, C/D box 115-1 | Dažnai (30–79%) | 1 ligoje |
| SNORD116-1small nucleolar RNA, C/D box 116-1 | Dažnai (30–79%) | 1 ligoje |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Dažnai (30–79%) | 6 ligose |
| SOD1superoxide dismutase 1 | Dažnai (30–79%) | 1 ligoje |
| SOX11SRY-box transcription factor 11 | Dažnai (30–79%) | 1 ligoje |
| SOX4SRY-box transcription factor 4 | Dažnai (30–79%) | 1 ligoje |
| SPENspen family transcriptional repressor | Dažnai (30–79%) | 1 ligoje |
| SPG11SPG11 vesicle trafficking associated, spatacsin | Dažnai (30–79%) | 2 ligose |
| SPRsepiapterin reductase | Dažnai (30–79%) | 1 ligoje |
| SPRED1sprouty related EVH1 domain containing 1 | Dažnai (30–79%) | 1 ligoje |
| SRCAPSnf2 related CREBBP activator protein | Dažnai (30–79%) | 1 ligoje |
| STAG2STAG2 cohesin complex component | Dažnai (30–79%) | 2 ligose |
| STILSTIL centriolar assembly protein | Dažnai (30–79%) | 4 ligose |
| STXBP1syntaxin binding protein 1 | Dažnai (30–79%) | 1 ligoje |
| SYNGAP1synaptic Ras GTPase activating protein 1 | Dažnai (30–79%) | 2 ligose |
| TAF15TATA-box binding protein associated factor 15 | Dažnai (30–79%) | 1 ligoje |
| TARDBPTAR DNA binding protein | Dažnai (30–79%) | 3 ligose |
| TATtyrosine aminotransferase | Dažnai (30–79%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Dažnai (30–79%) | 2 ligose |
| TBPTATA-box binding protein | Dažnai (30–79%) | 1 ligoje |
| TGFBR2transforming growth factor beta receptor 2 | Dažnai (30–79%) | 1 ligoje |
| TGIF1TGFB induced factor homeobox 1 | Dažnai (30–79%) | 4 ligose |
| THOC2THO complex subunit 2 | Dažnai (30–79%) | 2 ligose |
| TIMM8Atranslocase of inner mitochondrial membrane 8A | Dažnai (30–79%) | 2 ligose |
| TMEM138transmembrane protein 138 | Dažnai (30–79%) | 1 ligoje |
| TMEM216transmembrane protein 216 | Dažnai (30–79%) | 1 ligoje |
| TMEM231transmembrane protein 231 | Dažnai (30–79%) | 1 ligoje |
| TMEM237transmembrane protein 237 | Dažnai (30–79%) | 1 ligoje |
| TMEM240transmembrane protein 240 | Dažnai (30–79%) | 1 ligoje |
| TP53tumor protein p53 | Dažnai (30–79%) | 1 ligoje |
| TREX1three prime repair exonuclease 1 | Dažnai (30–79%) | 2 ligose |
| TRIM32tripartite motif containing 32 | Dažnai (30–79%) | 1 ligoje |
| TRIOtrio Rho guanine nucleotide exchange factor | Dažnai (30–79%) | 1 ligoje |
| TTC8tetratricopeptide repeat domain 8 | Dažnai (30–79%) | 1 ligoje |
| TTI2TELO2 interacting protein 2 | Dažnai (30–79%) | 1 ligoje |
| TUBG1tubulin gamma 1 | Dažnai (30–79%) | 1 ligoje |
| UBE4Bubiquitination factor E4B | Dažnai (30–79%) | 1 ligoje |
| UBQLN2ubiquilin 2 | Dažnai (30–79%) | 2 ligose |
| UNC13Aunc-13 homolog A | Dažnai (30–79%) | 1 ligoje |
| USP48ubiquitin specific peptidase 48 | Dažnai (30–79%) | 1 ligoje |
| USP8ubiquitin specific peptidase 8 | Dažnai (30–79%) | 1 ligoje |
| VAMP2vesicle associated membrane protein 2 | Dažnai (30–79%) | 1 ligoje |
| VAPBVAMP associated protein B and C | Dažnai (30–79%) | 1 ligoje |
| VPS13Avacuolar protein sorting 13 homolog A | Dažnai (30–79%) | 1 ligoje |
| WDPCPWD repeat containing planar cell polarity effector | Dažnai (30–79%) | 1 ligoje |
| YY1YY1 transcription factor | Dažnai (30–79%) | 2 ligose |
| ZIC2Zic family zinc finger 2 | Dažnai (30–79%) | 4 ligose |
| ZMYM3zinc finger MYM-type containing 3 | Dažnai (30–79%) | 1 ligoje |
| ZNF423zinc finger protein 423 | Dažnai (30–79%) | 1 ligoje |
| AARS1alanyl-tRNA synthetase 1 | Kartais (5–29%) | 1 ligoje |
| ACADSacyl-CoA dehydrogenase short chain | Kartais (5–29%) | 1 ligoje |
| ACSF3acyl-CoA synthetase family member 3 | Kartais (5–29%) | 1 ligoje |
| ACTL6Bactin like 6B | Kartais (5–29%) | 1 ligoje |
| AGAaspartylglucosaminidase | Kartais (5–29%) | 1 ligoje |
| ALKALK receptor tyrosine kinase | Kartais (5–29%) | 1 ligoje |
| ALS2alsin Rho guanine nucleotide exchange factor ALS2 | Kartais (5–29%) | 1 ligoje |
| AP3B2adaptor related protein complex 3 subunit beta 2 | Kartais (5–29%) | 1 ligoje |
| ARVCFARVCF delta catenin family member | Kartais (5–29%) | 1 ligoje |
| ARXaristaless related homeobox | Kartais (5–29%) | 1 ligoje |
| ATP10AATPase phospholipid transporting 10A (putative) | Kartais (5–29%) | 1 ligoje |
| ATP13A2ATPase cation transporting 13A2 | Kartais (5–29%) | 1 ligoje |
| ATP6V1AATPase H+ transporting V1 subunit A | Kartais (5–29%) | 1 ligoje |
| C4Acomplement C4A (Chido/Rodgers blood group) | Kartais (5–29%) | 1 ligoje |
| CACNA1Bcalcium voltage-gated channel subunit alpha1 B | Kartais (5–29%) | 1 ligoje |
| CACNA2D1calcium voltage-gated channel auxiliary subunit alpha2delta 1 | Kartais (5–29%) | 1 ligoje |
| CBScystathionine beta-synthase | Kartais (5–29%) | 2 ligose |
| CCR1C-C motif chemokine receptor 1 | Kartais (5–29%) | 1 ligoje |
| CDK19cyclin dependent kinase 19 | Kartais (5–29%) | 1 ligoje |
| CELF2CUGBP Elav-like family member 2 | Kartais (5–29%) | 1 ligoje |
| CISD2CDGSH iron sulfur domain 2 | Kartais (5–29%) | 1 ligoje |
| CLN8CLN8 transmembrane ER and ERGIC protein | Kartais (5–29%) | 1 ligoje |
| CLTCclathrin heavy chain | Kartais (5–29%) | 1 ligoje |
| CNKSR2connector enhancer of kinase suppressor of Ras 2 | Kartais (5–29%) | 1 ligoje |
| CNTNAP2contactin associated protein 2 | Kartais (5–29%) | 1 ligoje |
| COMTcatechol-O-methyltransferase | Kartais (5–29%) | 1 ligoje |
| CST3cystatin C | Kartais (5–29%) | 1 ligoje |
| CYFIP2cytoplasmic FMR1 interacting protein 2 | Kartais (5–29%) | 1 ligoje |
| DALRD3DALR anticodon binding domain containing 3 | Kartais (5–29%) | 1 ligoje |
| DDX3XDEAD-box helicase 3 X-linked | Kartais (5–29%) | 1 ligoje |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Kartais (5–29%) | 3 ligose |
| DHDDSdehydrodolichyl diphosphate synthase subunit | Kartais (5–29%) | 1 ligoje |
| DIP2BDIP2 acetate--CoA ligase B (putative) | Kartais (5–29%) | 1 ligoje |
| DLDdihydrolipoamide dehydrogenase | Kartais (5–29%) | 1 ligoje |
| EEF1A2eukaryotic translation elongation factor 1 alpha 2 | Kartais (5–29%) | 1 ligoje |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Kartais (5–29%) | 1 ligoje |
| ERLIN1ER lipid raft associated 1 | Kartais (5–29%) | 1 ligoje |
| FASFas cell surface death receptor | Kartais (5–29%) | 1 ligoje |
| FBXO28F-box protein 28 | Kartais (5–29%) | 1 ligoje |
| FGD1FYVE, RhoGEF and PH domain containing 1 | Kartais (5–29%) | 1 ligoje |
| FGF12fibroblast growth factor 12 | Kartais (5–29%) | 1 ligoje |
| FLT4fms related receptor tyrosine kinase 4 | Kartais (5–29%) | 1 ligoje |
| FOXG1forkhead box G1 | Kartais (5–29%) | 1 ligoje |
| FZR1fizzy and cell division cycle 20 related 1 | Kartais (5–29%) | 1 ligoje |
| GABBR2gamma-aminobutyric acid type B receptor subunit 2 | Kartais (5–29%) | 1 ligoje |
| GABRA2gamma-aminobutyric acid type A receptor subunit alpha2 | Kartais (5–29%) | 1 ligoje |
| GABRA5gamma-aminobutyric acid type A receptor subunit alpha5 | Kartais (5–29%) | 1 ligoje |
| GABRB2gamma-aminobutyric acid type A receptor subunit beta2 | Kartais (5–29%) | 1 ligoje |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Kartais (5–29%) | 1 ligoje |
| GATMglycine amidinotransferase | Kartais (5–29%) | 1 ligoje |
| GNEglucosamine (UDP-N-acetyl)-2-epimerase/N-acetylmannosamine kinase | Kartais (5–29%) | 1 ligoje |
| GP1BBglycoprotein Ib platelet subunit beta | Kartais (5–29%) | 1 ligoje |
| GPC4glypican 4 | Kartais (5–29%) | 1 ligoje |
| GRIN2Dglutamate ionotropic receptor NMDA type subunit 2D | Kartais (5–29%) | 1 ligoje |
| HCN1hyperpolarization activated cyclic nucleotide gated potassium channel 1 | Kartais (5–29%) | 1 ligoje |
| HCRThypocretin neuropeptide precursor | Kartais (5–29%) | 1 ligoje |
| HIRAhistone cell cycle regulator | Kartais (5–29%) | 1 ligoje |
| HLA-Bmajor histocompatibility complex, class I, B | Kartais (5–29%) | 1 ligoje |
| HLA-DQB1major histocompatibility complex, class II, DQ beta 1 | Kartais (5–29%) | 1 ligoje |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Kartais (5–29%) | 1 ligoje |
| HNRNPA2B1heterogeneous nuclear ribonucleoprotein A2/B1 | Kartais (5–29%) | 1 ligoje |
| IFNGR1interferon gamma receptor 1 | Kartais (5–29%) | 1 ligoje |
| IL10interleukin 10 | Kartais (5–29%) | 1 ligoje |
| IL12Ainterleukin 12A | Kartais (5–29%) | 1 ligoje |
| IL12A-AS1IL12A antisense RNA 1 | Kartais (5–29%) | 1 ligoje |
| IL23Rinterleukin 23 receptor | Kartais (5–29%) | 1 ligoje |
| IRF6interferon regulatory factor 6 | Kartais (5–29%) | 1 ligoje |
| JMJD1Cjumonji domain containing 1C | Kartais (5–29%) | 1 ligoje |
| JPH3junctophilin 3 | Kartais (5–29%) | 1 ligoje |
| KCNA2potassium voltage-gated channel subfamily A member 2 | Kartais (5–29%) | 1 ligoje |
| KCNB1potassium voltage-gated channel subfamily B member 1 | Kartais (5–29%) | 1 ligoje |
| KCNC2potassium voltage-gated channel subfamily C member 2 | Kartais (5–29%) | 1 ligoje |
| KCNH5potassium voltage-gated channel subfamily H member 5 | Kartais (5–29%) | 1 ligoje |
| KLRC4killer cell lectin like receptor C4 | Kartais (5–29%) | 1 ligoje |
| LAMP2lysosome associated membrane protein 2 | Kartais (5–29%) | 1 ligoje |
| LHCGRluteinizing hormone/choriogonadotropin receptor | Kartais (5–29%) | 1 ligoje |
| LRP1LDL receptor related protein 1 | Kartais (5–29%) | 1 ligoje |
| MAN1B1mannosidase alpha class 1B member 1 | Kartais (5–29%) | 1 ligoje |
| MAN2B1mannosidase alpha class 2B member 1 | Kartais (5–29%) | 2 ligose |
| MDGA2MAM domain containing glycosylphosphatidylinositol anchor 2 | Kartais (5–29%) | 1 ligoje |
| MEFVMEFV innate immunity regulator, pyrin | Kartais (5–29%) | 1 ligoje |
| MIR17HGmiR-17-92a-1 cluster host gene | Kartais (5–29%) | 1 ligoje |
| MMACHCmetabolism of cobalamin associated C | Kartais (5–29%) | 1 ligoje |
| MSX1msh homeobox 1 | Kartais (5–29%) | 1 ligoje |
| MTRR5-methyltetrahydrofolate-homocysteine methyltransferase reductase | Kartais (5–29%) | 1 ligoje |
| NAA10N-alpha-acetyltransferase 10, NatA catalytic subunit | Kartais (5–29%) | 1 ligoje |
| NAXDNAD(P)HX dehydratase | Kartais (5–29%) | 1 ligoje |
| NAXENAD(P)HX epimerase | Kartais (5–29%) | 1 ligoje |
| NDPnorrin cystine knot growth factor NDP | Kartais (5–29%) | 1 ligoje |
| NECAP1NECAP endocytosis associated 1 | Kartais (5–29%) | 1 ligoje |
| NECTIN1nectin cell adhesion molecule 1 | Kartais (5–29%) | 1 ligoje |
| NHSNHS actin remodeling regulator | Kartais (5–29%) | 1 ligoje |
| NPRL2NPR2 like, GATOR1 complex subunit | Kartais (5–29%) | 1 ligoje |
| NPRL3NPR3 like, GATOR1 complex subunit | Kartais (5–29%) | 1 ligoje |
| NRASNRAS proto-oncogene, GTPase | Kartais (5–29%) | 1 ligoje |
| NTRK2neurotrophic receptor tyrosine kinase 2 | Kartais (5–29%) | 1 ligoje |
| NUS1NUS1 dehydrodolichyl diphosphate synthase subunit | Kartais (5–29%) | 1 ligoje |
| ODC1ornithine decarboxylase 1 | Kartais (5–29%) | 1 ligoje |
| PACS2phosphofurin acidic cluster sorting protein 2 | Kartais (5–29%) | 1 ligoje |
| PARS2prolyl-tRNA synthetase 2, mitochondrial | Kartais (5–29%) | 1 ligoje |
| PDE11Aphosphodiesterase 11A | Kartais (5–29%) | 1 ligoje |
| PHGDHphosphoglycerate dehydrogenase | Kartais (5–29%) | 1 ligoje |
| PLA2G6phospholipase A2 group VI | Kartais (5–29%) | 1 ligoje |
| PNPpurine nucleoside phosphorylase | Kartais (5–29%) | 2 ligose |
| PNPLA6patatin like domain 6, lysophospholipase | Kartais (5–29%) | 1 ligoje |
| PPP2R2Bprotein phosphatase 2 regulatory subunit Bbeta | Kartais (5–29%) | 1 ligoje |
| PPP3CAprotein phosphatase 3 catalytic subunit alpha | Kartais (5–29%) | 1 ligoje |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Kartais (5–29%) | 1 ligoje |
| PTBP1polypyrimidine tract binding protein 1 | Kartais (5–29%) | 1 ligoje |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Kartais (5–29%) | 1 ligoje |
| RNF216ring finger protein 216 | Kartais (5–29%) | 1 ligoje |
| RPS6KA3ribosomal protein S6 kinase A3 | Kartais (5–29%) | 1 ligoje |
| RREB1ras responsive element binding protein 1 | Kartais (5–29%) | 1 ligoje |
| SACSsacsin molecular chaperone | Kartais (5–29%) | 1 ligoje |
| SCN3Asodium voltage-gated channel alpha subunit 3 | Kartais (5–29%) | 2 ligose |
| SCN8Asodium voltage-gated channel alpha subunit 8 | Kartais (5–29%) | 1 ligoje |
| SEC24CSEC24 homolog C, COPII component | Kartais (5–29%) | 1 ligoje |
| SIGMAR1sigma receptor chaperone 1 | Kartais (5–29%) | 1 ligoje |
| SLC13A5solute carrier family 13 member 5 | Kartais (5–29%) | 1 ligoje |
| SLC1A2solute carrier family 1 member 2 | Kartais (5–29%) | 1 ligoje |
| SMAD4SMAD family member 4 | Kartais (5–29%) | 1 ligoje |
| SORDsorbitol dehydrogenase | Kartais (5–29%) | 1 ligoje |
| SOX5SRY-box transcription factor 5 | Kartais (5–29%) | 1 ligoje |
| SPTBN1spectrin beta, non-erythrocytic 1 | Kartais (5–29%) | 1 ligoje |
| SPTLC1serine palmitoyltransferase long chain base subunit 1 | Kartais (5–29%) | 1 ligoje |
| SPTLC2serine palmitoyltransferase long chain base subunit 2 | Kartais (5–29%) | 1 ligoje |
| STAT4signal transducer and activator of transcription 4 | Kartais (5–29%) | 1 ligoje |
| SYNE1spectrin repeat containing nuclear envelope protein 1 | Kartais (5–29%) | 1 ligoje |
| SYNJ1synaptojanin 1 | Kartais (5–29%) | 1 ligoje |
| SZT2SZT2 subunit of KICSTOR complex | Kartais (5–29%) | 1 ligoje |
| TAF11TATA-box binding protein associated factor 11 | Kartais (5–29%) | 1 ligoje |
| TBX1T-box transcription factor 1 | Kartais (5–29%) | 1 ligoje |
| TBX4T-box transcription factor 4 | Kartais (5–29%) | 1 ligoje |
| TLR4toll like receptor 4 | Kartais (5–29%) | 1 ligoje |
| TNFRSF1ATNF receptor superfamily member 1A | Kartais (5–29%) | 1 ligoje |
| TP63tumor protein p63 | Kartais (5–29%) | 1 ligoje |
| TRAK1trafficking kinesin protein 1 | Kartais (5–29%) | 1 ligoje |
| TRMT2BtRNA methyltransferase 2B | Kartais (5–29%) | 1 ligoje |
| UBA5ubiquitin like modifier activating enzyme 5 | Kartais (5–29%) | 1 ligoje |
| UBAC2UBA domain containing 2 | Kartais (5–29%) | 1 ligoje |
| UBE3Aubiquitin protein ligase E3A | Kartais (5–29%) | 1 ligoje |
| UFD1ubiquitin recognition factor in ER associated degradation 1 | Kartais (5–29%) | 1 ligoje |
| UFSP2UFM1 specific peptidase 2 | Kartais (5–29%) | 1 ligoje |
| WFS1wolframin ER transmembrane glycoprotein | Kartais (5–29%) | 2 ligose |
| YWHAGtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | Kartais (5–29%) | 1 ligoje |
| ZEB2zinc finger E-box binding homeobox 2 | Kartais (5–29%) | 1 ligoje |
| ZFYVE26zinc finger FYVE-type containing 26 | Kartais (5–29%) | 1 ligoje |
| ZNF365zinc finger protein 365 | Kartais (5–29%) | 1 ligoje |
| AFG3L2AFG3 like matrix AAA peptidase subunit 2 | Retai (1–4 %) | 1 ligoje |
| CABP4calcium binding protein 4 | Retai (1–4 %) | 1 ligoje |
| CHRNA2cholinergic receptor nicotinic alpha 2 subunit | Retai (1–4 %) | 2 ligose |
| CHRNA4cholinergic receptor nicotinic alpha 4 subunit | Retai (1–4 %) | 1 ligoje |
| CHRNB2cholinergic receptor nicotinic beta 2 subunit | Retai (1–4 %) | 1 ligoje |
| CRHcorticotropin releasing hormone | Retai (1–4 %) | 1 ligoje |
| ELOVL5ELOVL fatty acid elongase 5 | Retai (1–4 %) | 1 ligoje |
| GJA5gap junction protein alpha 5 | Retai (1–4 %) | 1 ligoje |
| GJA8gap junction protein alpha 8 | Retai (1–4 %) | 1 ligoje |
| HALhistidine ammonia-lyase | Retai (1–4 %) | 1 ligoje |
| LGI1leucine rich glioma inactivated 1 | Retai (1–4 %) | 1 ligoje |
| LMNB1lamin B1 | Retai (1–4 %) | 1 ligoje |
| MICAL1microtubule associated monooxygenase, calponin and LIM domain containing 1 | Retai (1–4 %) | 1 ligoje |
| NAGSN-acetylglutamate synthase | Retai (1–4 %) | 1 ligoje |
| RELNreelin | Retai (1–4 %) | 1 ligoje |
| RORBRAR related orphan receptor B | Retai (1–4 %) | 1 ligoje |
| SMPD1sphingomyelin phosphodiesterase 1 | Retai (1–4 %) | 1 ligoje |
| BLTP1bridge-like lipid transfer protein family member 1 | Neužfiksuota | 1 ligoje |
| CDC42cell division cycle 42 | Neužfiksuota | 1 ligoje |
| CSF1Rcolony stimulating factor 1 receptor | Neužfiksuota | 1 ligoje |
| CYLDCYLD lysine 63 deubiquitinase | Neužfiksuota | 1 ligoje |
| EML1EMAP like 1 | Neužfiksuota | 1 ligoje |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Neužfiksuota | 1 ligoje |
| HDAC8histone deacetylase 8 | Neužfiksuota | 1 ligoje |
| KDM6Alysine demethylase 6A | Neužfiksuota | 1 ligoje |
| NOTCH3notch receptor 3 | Neužfiksuota | 1 ligoje |
| RLIMring finger protein, LIM domain interacting | Neužfiksuota | 1 ligoje |
| SLC45A1solute carrier family 45 member 1 | Neužfiksuota | 1 ligoje |
| USP27Xubiquitin specific peptidase 27 X-linked | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
- Abnormal social behavior44 genų
- Impaired executive functioning16 genų
- Shyness12 genų
- Inappropriate sexual behavior3 genų
- Pseudobulbar affect3 genų
- Reduced impulse control2 genų
- Non-epileptic seizure1 genas
- Abnormal demeanor
- Abnormal play
- Abnormal relationship
- Diagnostic behavioral phenotype
- Echophenomenon
- Impairment in personality functioning
- Recurrent maladaptive behavior
- Sensory behavioral abnormality
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.16-c6eea6bf.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites